- AdventHealth Research Institute
NKGen Biotech, Inc., a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell therapeutics, today announced that Anita Fletcher, M.D. has been appointed as the National Principal Investigator (“PI”) for its Phase 2a clinical trial of troculeucel, expanded enhanced autologous NK cell therapy, for the treatment of moderate Alzheimer’s disease (NCT06189963). In addition to Dr. Fletcher’s appointment as National PI, NKGen is pleased to announce AdventHealth Research Institute, Neuroscience Research in Orlando will be the first clinical site on the East Coast with the intent of enrolling moderate stage Alzheimer’s Disease (“AD”) patients in the very near term.
Read more about the announcement and the study by clicking the button below.
Recent News
AdventHealth Research Institute and NESTRE Health & Performance Announce Collaboration to Advance Neurocognitive Health and Performance Through Cognitive Training
“We are at a pivotal point in our understanding of neuroscience and in particular, neuroplasticity – the ability of neural networks in the brain to change through growth and reorganization. This new...
AdventHealth Research Contributed to New Method for Tracking Diet and Its Impacts on Human Health
Accurately determining food intake remains a challenge in nutrition research. A new study published in Nature Metabolism, introduces a metagenomics-powered approach to accurately track dietary intake...
AdventHealth Cancer Institute | Becker’s Hospital Review in the Top 100 Hospitals and Health Systems
The AdventHealth Cancer Institute has been recognized in Becker's Hospital Review as one of the top 100 hospitals and health systems in the country for its excellence in oncology.
Accelerating Orthopedic Innovation Through Research
In this blog Dr. Amir Kachooei shares his view on AdventHealth's orthopedic research efforts and the future of orthopedic medicine.
Dr. Wassim McHayleh Breast Cancer Research Patient Story - Florida Trend
Dr. Wassim McHayleh featured in article about breast cancer research.
Wassim McHayleh, MD | An Investigational Breast Cancer Drug Has Been a Game Changer for a Central FL Patient
Florida Trend for Breast Cancer Month features Dr. McHayleh and his clinical trial Tropion! A participant in the study was declared cancer-free after about 5 months of treatment.